Prevalence of Alzheimer's dementia and its risk factors in community-dwelling elderly Koreans

Psychiatry Investigation

Volumn 5, Issue 2, 2008, Pages 78-85

  Choi, Seok Ju ^a   Jung, Sung Soo ^b   You, Young Sun ^b   Shin, Bae Seob ^b   Kim, Ji Eun ^b   Yoon, Sung Wook ^b   Jeon, Dong Wook ^b   Baek, Jun Hyung ^b   Park, Sung Woo ^c   Lee, Jung Goo ^c   Kim, Young Hoon ^c  

^a Department of Psychiatry   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Inje University   (South Korea)

Author keywords

Alzheimer's dementia; Metabolic syndrome; Mild cognitive impairment; Prevalence; Risk factor

Indexed keywords

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL DEMENTIA RATING; COGNITIVE DEFECT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; EDUCATION; FEMALE; GERIATRIC DEPRESSION SCALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MINI MENTAL STATE EXAMINATION; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PHYSICAL EXAMINATION; PREVALENCE; RATING SCALE; RISK FACTOR; URBAN POPULATION;

EID: 46949083764     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2008.5.2.78     Document Type: Article

References (58)

1. Gleason OC. Delirium. Am Fam Physician 2003;67:1027-1034.
2. Suh GH, Kim JK, Cho MJ. Community study of dementia in the older Korean rural population. Aust N Z J Psychiatry 2003;37:606-612.
3. Hendrie HC, Osuntokun BO. Hall KS, Oqunnivi AO, Hui SL, Unverzaqt FW, et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry 1995; 152:1485-1492.
4. Folstein MF, Bassctt SS, Anthony JC, Romanoski AJ. Nestadt GR. Dementia: case ascertainment in a community survey. J Gerontol 1991;46:M132-138.
5. Lee DY, Lee JII, Ju YS, Lee KU, Kim KW, Jhoo JH, et al. The prevalence in older people in an urban population of Korea: the Seoul study. Am Geriat Soc 2002;50:1233-1239.
6. Suh GH, Kim JK, Cho MJ. Community study of dementia in the older Korean rural population. Aust N Z J Psychiatry 2003;37:606-612.
7. Park J, Ko HJ, Park YN, Jung CH. Dementia among the elderly in a rural Korean community. Br J Psychiatry 1994;164:796-801.
8. The incidence of dementia in Canada. The Canadian study of Health Aging Working Group. Neurology 2000;55:66-73.
9. Petersen RC, Morris JC. Mild cognitive impairment as a clinical entity and treatment target. Arch Neurol 2005;62:1160-1163.
10. Ritchie K, Artcro S, Touchon .J. Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001; 56:37-42.
11. Ganguli M. Mild cognitive impairment and the 7 uses of cpidemiology. Alzheimer Dis Assoc Disord 2006;20:S52-57.
12. Graham JE, Rockwood K, Beattie BL, Eastwood R, Gauthier S, Tuokko H, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 1997;21:1793-1796.
13. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, et al. Natural history of mild cognitive impairment in older persons. Neurology 2002;23:59-205.
14. Lopez OL, Jagust WJ, DeKosky ST, Becker JT, Fitzpatriek A, Dulberg C, et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol 2003;60:1385-1389.
15. Feldman HH, Jacova C. Mild cognitive impairment. Am J Geriatr Psychiatry 2005;13:645-655.
16. Takechi H. Hypertension as a risk factor of dementia and cognitive decline in the elderly. Nippon Ronen Igakkai Zasshi 2007;44:433-436.
17. Boston PF, Dennis MS, Jaggcr C. Factors associated with vascular dementia in an elderly community population. Int J Geriatr Psychiatry 1999;14:761-766.
18. Brayne C, Gill C, Huppert FA, Barkley C, Gehlhaar E, Girling DM. et al. Vascular risks and incident dementia: results from a cohort study of the very old. Dement Geriatr Cogn Disord 1998;9:175-180.
19. Yaffe K. Metabolic syndrome and cognitive decline. Curr Alzheimer Res 2007;4:123-126.
20. Launer LJ. Demonstrating the case that AD is a vascular disease: epidemiologic evidence. Ageing Res Rev 2002;1:61-77.
21. Kalmijn S, Feskens EJ, Launer LJ, Stijnen T, Kromhout D. Glucose intolerance, hyperinsulinacmia and cognitive function in a general population of elderly men. Diabetologia 1995;38:1096-1102.
22. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med 2000:160:174-180.
23. Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels. statin use, and cognitive function in older women. Arch Neurol 2002; 59:378-384.
24. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI. et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292:2237-2242.
25. Lee JH, Lee KU, Lee DY, Kim KW, Jhoo JH, Kim JH, et al. Development of the Korean version of the Consortium to Establish a Resistry for Alzheimer's Disease Assessment Packet (CERAD-K): clinical and neuropsychological assessment batteries. J Gerontol B Psychol Sci Soc Sci 2002;57:P47-53.
26. Bae JN, Cho MJ. Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients. J Psychosom Res 2004;57:297-305.
27. Morris JC, Heyman A, Mohs RC, Huqhes JP, van Belle G, Fillenbaum G, et al. The Consortium to Establish a Resistry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's Disease. Neurology 1989;39:1159-1165.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental disorder, 4th edition-text revision. Washington, DC: American Psychiatric Association, 2000. p. 243-255.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
30. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
31. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7:486-488.
32. Morris JC. The Clinical Dementia Rating (CT)R): current version and scoring rules. Neurology 1993;43:2412-2414.
33. Hughes CP, Berg L, Danziger WL, Cohen LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140: 566-572.
34. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001;58:397-405.
35. Suh GH, Kim JK, Yeon BK, Park SK, Yoo KY, Yang BK, et al. Prevalence and risk factors of dementia and depression in the elderly. J Korean Neuropsychiatr Assoc 2000;39:809-824.
36. Cho MJ, Hahm BJ, Jhoo JH, Bae JN, Kwon JS. Prevalence of cognitive impairment and depressive symtoms among the elderly in an urban community. J Korean Neuropsychiatr Assoc 1998;37:352-362.
37. Bae JN. Dementia, depressive disorders and substance use disorders among the urban elderly in Korea: Seoul National Univ, 2001, p.24-27.
38. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140: 566-572.
39. Ueda K, Kawano H, Hasuo Y, Fujishima M. Prevalence and etiology dementia in a Japanese community. Stroke 1992;23:798-803.
40. Li G, Shen YC, Chen CH, Zhao Yw, Li SR, Lu M. An epidemiological survey of age-related dementia in an urban area of Beijing. Acta Psychiatr Scand 1989;79:557-563.
41. Zhang M, Katzman R, Salmon D, Jin H, Cai GJ, Wang ZY, et al. The prevalence of dementia and Alzheimer's disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990;27:428-437.
42. Maioli F, Covcri M, Pagni P, Chiandetti C, Marchetti C, Ciarrocchi R, et al. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit. Arch Gerontol Geriatr 2007;44 Suppl 1:233-241.
43. Di Carlo A, Lamassa M, Baldereschi M, Inzitari M, Scafato E, Farchi G, et al. CPND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia. Neurology 2007;68:1909-1916.
44. Jorm AF. The epidemiology of Alzheimer's disease and related disorder. London, England: Chapman & Hall, 1990, p.34-37.
45. Stern Y, Gurland B, Tatemichi TK, Tang MX, Wilder D, Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 1994;271:1004-1010.
46. Scarmeas N, Zarahn E, Anderson KE, Habeck CG, Hilton J, Flynn J, et al. Association of life activities with cerebral blood flow in Alzheimer disease: implications for the cognitive reserve hypothesis. Arch Neurol 2003;60:359-365.
47. Katzman R. Education and the prevalence of dementia and Alz- heimer's disease. Neurology 1993;43:13-20.
48. Li G, Shen YC, Chen CH, Zhao YW, Li SR, Lu M. An epidemiological survey of age-related dementia in an urban area of Beijing. Acta Psychiatr Scand 1989;79:557-563.
49. Wang W, Wu S, Cheng X, Dai H, Ross K, Du X, et al. Prevalence of Alzheimer's disease and other dementing disorders in an urban community of Beijing, China. Neuroepidemiology 2000;19:194-200.
50. Forette F, Boiler F. Hypertension and the risk of dementia in the elderly. Am J Med 1991;90:14S-19S.
51. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala EL, Haapala I, et al. Metabolic syndrome and cognitive function: a population-based follow-up study in elderly women. Dement Geriatr Coqn Disord 2007;23:29-34.
52. Evans RM, Emsley CL, Gao S, Sahota A, Hall KS, Farlow MR, et al. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans. Neurology 2000;54:240-242.
53. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, et al. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 1998;17:14-20.
54. Romas SN, fang MX, Berglund L, Mayeux R. APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology 1999;53:517-521.
55. Moroney JT, Tang MX, Berglund L, Small S, Merchant C, Bell K,et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. JAMA 1999;282:254-260.
56. Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 2002; 59378-384.
57. Zimetbaum P, Frishman WH, Ooi WL, Derman MP, Aronson M, Gidez LI, et al. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study. Arterioscler Thromb 1992;12:416-423.
58. Yoshitake T, Kiyohara Y, Kato 1, Ohmura T, Iwamoto H, Nakayama K, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995;45:1161-1168.